Complement-mediated regulation of tissue factor activity in endothelium

doi:10.1084/jem.182.6.1807

This Article

	Full Text (PDF, 985K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Saadi, S.
	Articles by Platt, J. L.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Saadi, S.
	Articles by Platt, J. L.


Social Bookmarking

	What's this?

ARTICLES

Complement-mediated regulation of tissue factor activity in endothelium

S Saadi, RA Holzknecht, CP Patte, DM Stern and JL Platt
Department of Surgery, Duke University, Durham, North Carolina 27710, USA.

Inflammation and immunity may be associated with endothelial cell (EC) injury and thrombus formation. We explored the mechanisms through which a humoral immune response directed against the endothelium might promote coagulation. Using the interaction of anti-EC antibodies and complement (C) with cultured EC as a model, we studied the expression and function of tissue factor, a cofactor for factor VIIa-mediated conversion of factor X to Xa. Exposure of EC to anti-EC antibodies and C in sublytic amounts stimulated the synthesis of tissue factor over a period of 16-42 h. Cell surface expression of tissue factor activity required activation of C and assembly of the membrane attack complex, because expression was inhibited by soluble CR1 and was not detected in the absence of C8. Elaboration of tissue factor messenger RNA was observed over a period of 8-30 h and required protein synthesis. Expression of tissue factor was not a direct consequence of the action of C on the EC but was a secondary response that required as an intermediate step the release of interleukin 1 alpha, an early product of the EC response to C activation. These findings suggest that, after the assembly of membrane attack complex on EC, the production of tissue factor and initiation of coagulation in a blood vessel depend on the production of interleukin 1 alpha and on its availability to stimulate affected EC.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Kinderlerer, A. R., Pombo Gregoire, I., Hamdulay, S. S., Ali, F., Steinberg, R., Silva, G., Ali, N., Wang, B., Haskard, D. O., Soares, M. P., Mason, J. C. (2009). Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin. Blood 113: 1598-1607 [Abstract] [Full Text]
Shimizu, A., Hisashi, Y., Kuwaki, K., Tseng, Y.-L., Dor, F. J.M.F., Houser, S. L., Robson, S. C., Schuurman, H.-J., Cooper, D. K.C., Sachs, D. H., Yamada, K., Colvin, R. B. (2008). Thrombotic Microangiopathy Associated with Humoral Rejection of Cardiac Xenografts from {alpha}1,3-Galactosyltransferase Gene-Knockout Pigs in Baboons. Am. J. Pathol. 172: 1471-1481 [Abstract] [Full Text]
Kinderlerer, A. R., Ali, F., Johns, M., Lidington, E. A., Leung, V., Boyle, J. J., Hamdulay, S. S., Evans, P. C., Haskard, D. O., Mason, J. C. (2008). KLF2-dependent, Shear Stress-induced Expression of CD59: A NOVEL CYTOPROTECTIVE MECHANISM AGAINST COMPLEMENT-MEDIATED INJURY IN THE VASCULATURE. J. Biol. Chem. 283: 14636-14644 [Abstract] [Full Text]
Brunn, G. J., Saadi, S., Platt, J. L. (2008). Constitutive Repression of Interleukin-1{alpha} in Endothelial Cells. Circ. Res. 102: 823-830 [Abstract] [Full Text]
Rao, D. A., Tracey, K. J., Pober, J. S. (2007). IL-1{alpha} and IL-1beta Are Endogenous Mediators Linking Cell Injury to the Adaptive Alloimmune Response. J. Immunol. 179: 6536-6546 [Abstract] [Full Text]
Wang, H., Arp, J., Liu, W., Faas, S. J., Jiang, J., Gies, D. R., Ramcharran, S., Garcia, B., Zhong, R., Rother, R. P. (2007). Inhibition of Terminal Complement Components in Presensitized Transplant Recipients Prevents Antibody-Mediated Rejection Leading to Long-Term Graft Survival and Accommodation. J. Immunol. 179: 4451-4463 [Abstract] [Full Text]
Yeoh, A. S.J., Gibson, R. J., Yeoh, E. E.K., Bowen, J. M., Stringer, A. M., Giam, K. A., Keefe, D. M.K. (2007). A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-{kappa}B, COX-1, and COX-2. Molecular Cancer Therapeutics 6: 2319-2327 [Abstract] [Full Text]
Wehner, J., Morrell, C. N., Reynolds, T., Rodriguez, E. R., Baldwin, W. M. III (2007). Antibody and Complement in Transplant Vasculopathy. Circ. Res. 100: 191-203 [Abstract] [Full Text]
Black, S. M., Grehan, J. F., Rivard, A. L., Benson, B. A., Wahner, A. E., Koch, A. E., Levay-Young, B. K., Dalmasso, A. P. (2006). Porcine Endothelial Cells and Iliac Arteries Transduced with AdenoIL-4 Are Intrinsically Protected, through Akt Activation, against Immediate Injury Caused by Human Complement. J. Immunol. 177: 7355-7363 [Abstract] [Full Text]
Tinckam, K. J., Chandraker, A. (2006). Mechanisms and Role of HLA and non-HLA Alloantibodies. CJASN 1: 404-414 [Abstract] [Full Text]
Brunn, G. J., Saadi, S., Platt, J. L. (2006). Differential Regulation of Endothelial Cell Activation by Complement and Interleukin 1{alpha}. Circ. Res. 98: 793-800 [Abstract] [Full Text]
Fischetti, F., Durigutto, P., Pellis, V., Debeus, A., Macor, P., Bulla, R., Bossi, F., Ziller, F., Sblattero, D., Meroni, P., Tedesco, F. (2005). Thrombus formation induced by antibodies to {beta}2-glycoprotein I is complement dependent and requires a priming factor. Blood 106: 2340-2346 [Abstract] [Full Text]
Shimizu, A., Yamada, K., Yamamoto, S., Lavelle, J. M., Barth, R. N., Robson, S. C., Sachs, D. H., Colvin, R. B. (2005). Thrombotic Microangiopathic Glomerulopathy in Human Decay Accelerating Factor-Transgenic Swine-to-Baboon Kidney Xenografts. J. Am. Soc. Nephrol. 16: 2732-2745 [Abstract] [Full Text]
Mendicino, M., Liu, M., Ghanekar, A., He, W., Koscik, C., Shalev, I., Javadi, M., Turnbull, J., Chen, W., Fung, L., Sakamoto, S., Marsden, P., Waddell, T. K., Phillips, M. J., Gorczynski, R., Levy, G. A., Grant, D. (2005). Targeted Deletion of Fgl-2/Fibroleukin in the Donor Modulates Immunologic Response and Acute Vascular Rejection in Cardiac Xenografts. Circulation 112: 248-256 [Abstract] [Full Text]
Koch, C. A., Kanazawa, A., Nishitai, R., Knudsen, B. E., Ogata, K., Plummer, T. B., Butters, K., Platt, J. L. (2005). Intrinsic Resistance of Hepatocytes to Complement-Mediated Injury. J. Immunol. 174: 7302-7309 [Abstract] [Full Text]
Bossi, F., Fischetti, F., Pellis, V., Bulla, R., Ferrero, E., Mollnes, T. E., Regoli, D., Tedesco, F. (2004). Platelet-Activating Factor and Kinin-Dependent Vascular Leakage as a Novel Functional Activity of the Soluble Terminal Complement Complex. J. Immunol. 173: 6921-6927 [Abstract] [Full Text]
Yamada, K., Miwa, T., Liu, J., Nangaku, M., Song, W.-C. (2004). Critical Protection from Renal Ischemia Reperfusion Injury by CD55 and CD59. J. Immunol. 172: 3869-3875 [Abstract] [Full Text]
Saadi, S., Takahashi, T., Holzknecht, R. A., Platt, J. L. (2004). Pathways to Acute Humoral Rejection. Am. J. Pathol. 164: 1073-1080 [Abstract] [Full Text]
Longo, C. R., Arvelo, M. B., Patel, V. I., Daniel, S., Mahiou, J., Grey, S. T., Ferran, C. (2003). A20 Protects From CD40-CD40 Ligand-Mediated Endothelial Cell Activation and Apoptosis. Circulation 108: 1113-1118 [Abstract] [Full Text]
Holzknecht, Z. E., Kuypers, K. L., Plummer, T. B., Williams, J., Bustos, M., Gores, G. J., Brunn, G. J., Platt, J. L. (2002). Apoptosis and Cellular Activation in the Pathogenesis of Acute Vascular Rejection. Circ. Res. 91: 1135-1141 [Abstract] [Full Text]
SAADI, S., WRENSHALL, L. E., PLATT, J. L. (2002). Regional manifestations and control of the immune system. FASEB J. 16: 849-856 [Abstract] [Full Text]
Raife, T. J., Lentz, S. R., Atkinson, B. S., Vesely, S. K., Hessner, M. J. (2002). Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood 99: 437-442 [Abstract] [Full Text]
Dobrina, A., Pausa, M., Fischetti, F., Bulla, R., Vecile, E., Ferrero, E., Mantovani, A., Tedesco, F. (2002). Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo. Blood 99: 185-192 [Abstract] [Full Text]
McLaughlin, F., Ludbrook, V. J., Cox, J., von Carlowitz, I., Brown, S., Randi, A. M. (2001). Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation. Blood 98: 3332-3339 [Abstract] [Full Text]
Praprotnik, S., Blank, M., Levy, Y., Tavor, S., Boffa, M.-C., Weksler, B., Eldor, A., Shoenfeld, Y. (2001). Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells. Int Immunol 13: 203-210 [Abstract] [Full Text]
SAMSTEIN, B., PLATT, J. L. (2001). Physiologic and Immunologic Hurdles to Xenotransplantation. J. Am. Soc. Nephrol. 12: 182-193 [Abstract] [Full Text]
Lidington, E. A., Haskard, D. O., Mason, J. C. (2000). Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury. Blood 96: 2784-2792 [Abstract] [Full Text]
Saadi, S., Holzknecht, R. A., Patte, C. P., Platt, J. L. (2000). Endothelial Cell Activation by Pore-Forming Structures : Pivotal Role for Interleukin-1{alpha}. Circulation 101: 1867-1873 [Abstract] [Full Text]
Abraham, E. (2000). Coagulation Abnormalities in Acute Lung Injury and Sepsis. Am. J. Respir. Cell Mol. Bio. 22: 401-404 [Full Text]
Dalmasso, A. P., Benson, B. A., Johnson, J. S., Lancto, C., Abrahamsen, M. S. (2000). Resistance Against the Membrane Attack Complex of Complement Induced in Porcine Endothelial Cells with a Gal{alpha}(1-3)Gal Binding Lectin: Up-Regulation of CD59 Expression. J. Immunol. 164: 3764-3773 [Abstract] [Full Text]
Goddard, M J, Foweraker, J E, Wallwork, J (2000). Xenotransplantation--2000. J. Clin. Pathol. 53: 44-48 [Full Text]
MORIGI, M., ZOJA, C., COLLEONI, S., ANGIOLETTI, S., IMBERTI, B., DONADELLI, R., REMUZZI, A., REMUZZI, G. (1999). Xenogeneic Serum Promotes Leukocyte-Endothelium Interaction under Flow through Two Temporally Distinct Pathways: Role of Complement and NuclearFactor-{kappa}B. J. Am. Soc. Nephrol. 10: 2197-2207 [Abstract] [Full Text]
Qian, Z., Wasowska, B. A., Behrens, E., Cangello, D. L., Brody, J. R., Kadkol, S. S., Horwitz, L., Liu, J., Lowenstein, C., Hess, A. D., Sanfilippo, F., Baldwin, W. M. III (1999). C6 Produced by Macrophages Contributes to Cardiac Allograft Rejection. Am. J. Pathol. 155: 1293-1302 [Abstract] [Full Text]
Mason, J. C., Yarwood, H., Sugars, K., Morgan, B. P., Davies, K. A., Haskard, D. O. (1999). Induction of Decay-Accelerating Factor by Cytokines or the Membrane-Attack Complex Protects Vascular Endothelial Cells Against Complement Deposition. Blood 94: 1673-1682 [Abstract] [Full Text]
McLaughlin, F, Ludbrook, V., Kola, I, Campbell, C., Randi, A. (1999). Characterisation of the tumour necrosis factor (TNF)-(alpha) response elements in the human ICAM-2 promoter. J. Cell Sci. 112: 4695-4703 [Abstract]
Selvan, R. S., Kapadia, H. B., Platt, J. L. (1998). Complement-Induced Expression of Chemokine Genes in Endothelium: Regulation by IL-1-Dependent and -Independent Mechanisms. J. Immunol. 161: 4388-4395 [Abstract] [Full Text]
Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., Barnathan, E. S., McCrae, K. R., Hug, B. A., Schmidt, A.-M., Stern, D. M. (1998). Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders. Blood 91: 3527-3561 [Full Text]
Tedesco, F., Pausa, M., Nardon, E., Introna, M., Mantovani, A., Dobrina, A. (1997). The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity. JEM 185: 1619-1628 [Abstract] [Full Text]
Robson, S. C., Kaczmarek, E., Siegel, J. B., Candinas, D., Koziak, K., Millan, M., Hancock, W. W., Bach, F. H. (1997). Loss of ATP Diphosphohydrolase Activity with Endothelial Cell Activation. JEM 185: 153-164 [Abstract] [Full Text]
Mollnes, T. E., Harboe, M. (1996). Recent Advances: Clinical immunology. BMJ 312: 1465-1469 [Abstract] [Full Text]
Mason, J. C., Lidington, E. A., Ahmad, S. R., Haskard, D. O. (2002). bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction. Am. J. Physiol. Cell Physiol. 282: C578-C587 [Abstract] [Full Text]